Cansortium Inc. (OTCMKTS:CNTMF – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 208,442 shares, a growth of 370.1% from the May 14th total of 44,344 shares. Based on an average daily trading volume, of 516,366 shares, the days-to-cover ratio is presently 0.4 days.
Cansortium Price Performance
Shares of OTCMKTS:CNTMF opened at $0.02 on Thursday. Cansortium has a 1-year low of $0.02 and a 1-year high of $0.09. The business has a 50-day moving average price of $0.03 and a two-hundred day moving average price of $0.04.
Cansortium (OTCMKTS:CNTMF – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported ($0.16) earnings per share for the quarter. During the same period in the previous year, the company earned ($0.14) earnings per share.
About Cansortium
Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.
Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.
Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.
Featured Stories
- Five stocks we like better than Cansortium
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.
